We found no differences in plasma SPARC concentrations between patients with or without T2D, while Wang et al. (2015) observed a correlation between serum SPARC concentrations and the homeostatic model assessment of insulin resistance (HOMA‐IR) index in patients with CAD. The gene discussed is SPARC; the disease is coronary artery disorder.